News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2025 Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data Yael L. Maxwell May 20, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2021 Transradial PCI Bests Femoral Access in Complex Cases: COLOR Michael O'Riordan May 21, 2021
News Conference News EuroPCR 2021 Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN L.A. McKeown May 21, 2021
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News EuroPCR 2017 Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis Michael O'Riordan May 19, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Conference News EuroPCR 2015 PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI Caitlin E. Cox May 19, 2015